Gf Fund Management Co. Ltd. Biotechnology

Gf Fund Management Co. Ltd.

$4.97 Trillion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
THRD Third Harmonic Bio, Inc.	$219M	$6.07 Million 0.0% of portfolio	1,118	Q1 2025 Added 18.18%
ALLO Allogene Therapeutics, Inc.	$217M	$6.07 Million 0.0% of portfolio	5,368	Q1 2025 Added 21.92%
OLMA Olema Pharmaceuticals, Inc.	$187M	$6.06 Million 0.0% of portfolio	1,422	Q1 2025 Added 18.2%
RCKT Rocket Pharmaceuticals, Inc.	$243M	$5.72 Million 0.0% of portfolio	2,333	Q1 2025 Added 21.89%
YMAB Y M Abs Therapeutics, Inc.	$212M	$5.01 Million 0.0% of portfolio	1,111	Q1 2025 Added 18.19%
ACIU Ac Immune Sa	$203M	$4.98 Million 0.0% of portfolio	2,454	Q1 2025 Added 18.15%
CDXS Codexis, Inc.	$212M	$4.93 Million 0.0% of portfolio	2,019	Q1 2025 Added 18.14%
DSGN Design Therapeutics, Inc.	$225M	$4.88 Million 0.0% of portfolio	1,449	Q1 2025 Added 21.87%
SCPH Sc Pharmaceuticals Inc.	$155M	$4.73 Million 0.0% of portfolio	1,242	Q1 2025 Added 18.17%
EDIT Editas Medicine, Inc.	$224M	$4.65 Million 0.0% of portfolio	2,113	Q1 2025 Added 15.46%
LRMR Larimar Therapeutics, Inc.	$149M	$4.58 Million 0.0% of portfolio	1,583	Q1 2025 Added 18.13%
OMER Omeros Corp	$225M	$4.45 Million 0.0% of portfolio	1,483	Q1 2025 Added 21.86%
FDMT 4 D Molecular Therapeutics, Inc.	$149M	$4.26 Million 0.0% of portfolio	1,147	Q1 2025 Added 18.13%
VYGR Voyager Therapeutics, Inc.	$128M	$4.21 Million 0.0% of portfolio	1,355	Q1 2025 Added 18.13%
ENTA Enanta Pharmaceuticals Inc	$152M	$3.97 Million 0.0% of portfolio	525	Q1 2025 Added 17.98%
ALEC Alector, Inc.	$148M	$3.4 Million 0.0% of portfolio	2,429	Q1 2025 Added 13.24%
FATE Fate Therapeutics Inc	$121M	$3.07 Million 0.0% of portfolio	2,737	Q1 2025 Added 14.47%
NKTX Nkarta, Inc.	$104M	$2.91 Million 0.0% of portfolio	1,751	Q1 2025 Added 18.15%
CCCC C4 Therapeutics, Inc.	$112M	$2.5 Million 0.0% of portfolio	1,751	Q1 2025 Added 18.15%
ELYM Eliem Therapeutics, Inc.	$109M	$2 Million 0.0% of portfolio	1,616	Q1 2025 Added 14.45%
MGNX Macrogenics Inc	$109M	$1.88 Million 0.0% of portfolio	1,557	Q1 2025 Added 18.13%
TCRX T Scan Therapeutics, Inc.	$34.8M	$1.77 Million 0.0% of portfolio	1,218	Q1 2025 Added 18.14%
PLRX Pliant Therapeutics, Inc.	$77.4M	$1.75 Million 0.0% of portfolio	1,509	Q1 2025 Added 18.08%
BMEA Biomea Fusion, Inc.	$53M	$1.62 Million 0.0% of portfolio	899	Q1 2025 Added 14.67%
PYXS Pyxis Oncology, Inc.	$40M	$1.57 Million 0.0% of portfolio	1,429	Q1 2025 Added 14.41%
STRO Sutro Biopharma, Inc.	$48M	$1.42 Million 0.0% of portfolio	1,982	Q1 2025 Added 14.5%
PEPG Pep Gen Inc.	$33.1M	$897,000 0.0% of portfolio	808	Q1 2025 Added 18.13%
IGMS Igm Biosciences, Inc.	$37.1M	$802,000 0.0% of portfolio	716	Q4 2024 New
MRSN Mersana Therapeutics, Inc.	$31.1M	$768,000 0.0% of portfolio	2,594	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.